Findings from a CHOP/Penn Medicine study could lead to treatment for patients with lung disease, including acute respiratory distress syndrome due to COVID-19.
News & Blog
GET TO KNOW US!
AllAllergyAsthmaBest PracticesCase StudiesClinical ResearchCNS/NeurologyConsortiaCriterium NewsData ManagementDermatologyEDCFDAGastroenterologyGlobal Clinical ResearchHematologyIndustry NewsInfectious DiseaseIVR-IWR IxRSMedical DevicesMen's HealthMetabolic SyndromeOncologyOphthalmologyOrphan DiseasesOutsourcingPain ManagementPharmaceutical DevelopmentPress ReleasesPublic InterestTranslational ResearchTrial TechnologyUrologyWomen's Health
Moleculin Announces Positive Trial Data with 100% Safe Delivery of p-STAT3 Inhibitor and Efficacy in Majority of Patients Preliminary results from phase 1 clinical trial of WP1220 for treatment of
Research from the O’Neal Comprehensive Cancer Center at UAB finds patients treated outside of NCCN Guidelines recommendations had significantly higher direct costs. A new study from the O’Neal Comprehensive Cancer
The U.S. Food and Drug Administration is warning consumers not to purchase or use drugs advertised nationwide as a “healthy man alternative to the little blue pill” or “healthy man,”
3D printing is a process that creates a three-dimensional object by building successive layers of raw material. Objects are produced from a digital 3D file, such as a computer-aided design
There are approximately 7,000 rare diseases affecting an estimated 30 million people in the United States. Many of these diseases are serious or life-threatening and it is estimated that half
- Researchers Identify “Druggable” Signaling Pathway that Stimulates Lung Tissue Repair
- Positive Trial Data with 100% Safe Delivery
- Following NCCN Guidelines for Metastatic Breast Cancer Results in Lower Costs for Patients
- Consumer Warning for Erectile Dysfunction Pills
- 3D Printing for Medical Devices